Getting a therapy approved is only half the commercial battle. The other half is making sure payers, providers, and patients actually have a path to it — at a price and under terms that make sense for everyone involved. That's the work of pharmaceutical market access consulting: helping manufacturers build the strategy, evidence, and stakeholder relationships needed to turn clinical value...